Evidence map›Paper›PMID 26178321›Full record

ArticleParticle and fibre toxicology2015

Cytotoxic and inflammatory potential of size-fractionated particulate matter collected repeatedly within a small urban area.

Errol M Thomson, Dalibor Breznan, Subramanian Karthikeyan, Christine MacKinnon-Roy, Jean-Pierre Charland, Ewa Dabek-Zlotorzynska, Valbona Celo, Prem Kumarathasan, Jeffrey R Brook, Renaud Vincent

Open access · goldAbstract read
In one paragraph

Article in Particle and fibre toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 103 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Morin Protects Human Respiratory Cells from PMInternational journal of environmental research and public health · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. In vitro toxicological evaluation of surgical smoke from human tissue.Journal of occupational medicine and toxicology (London, England) · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Errol M ThomsonInhalation Toxicology Laboratory, Hazard Identification Division, Environmental Health Science and Research Bureau, Health Canada, 0802B Tunney's Pasture, Ottawa, ON, K1A 0K9, Canada. errol.thomson@hc-sc.gc.ca.
Dalibor BreznanInhalation Toxicology Laboratory, Hazard Identification Division, Environmental Health Science and Research Bureau, Health Canada, 0802B Tunney's Pasture, Ottawa, ON, K1A 0K9, Canada. dalibor.breznan@hc-sc.gc.ca.
Subramanian KarthikeyanInhalation Toxicology Laboratory, Hazard Identification Division, Environmental Health Science and Research Bureau, Health Canada, 0802B Tunney's Pasture, Ottawa, ON, K1A 0K9, Canada. subramanian.karthikeyan@hc-sc.gc.ca.
Christine MacKinnon-RoyInhalation Toxicology Laboratory, Hazard Identification Division, Environmental Health Science and Research Bureau, Health Canada, 0802B Tunney's Pasture, Ottawa, ON, K1A 0K9, Canada. christine.mackinnon-roy@cihr-irsc.gc.ca.
Jean-Pierre CharlandAnalysis and Air Quality Section, Air Quality Research Division, Atmospheric Science and Technology Directorate, Environment Canada, Ottawa, ON, K1A 0H3, Canada. jean-pierre.charland@ec.gc.ca.
Ewa Dabek-ZlotorzynskaAnalysis and Air Quality Section, Air Quality Research Division, Atmospheric Science and Technology Directorate, Environment Canada, Ottawa, ON, K1A 0H3, Canada. ewa.dabek@ec.gc.ca.
Valbona CeloAnalysis and Air Quality Section, Air Quality Research Division, Atmospheric Science and Technology Directorate, Environment Canada, Ottawa, ON, K1A 0H3, Canada. valbona.celo@ec.gc.ca.
Prem KumarathasanMechanistic Studies Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, K1A 0K9, Canada. premkumari.kumarathasan@hc-sc.gc.ca.
Jeffrey R BrookAir Quality Processes Research Section, Air Quality Research Division, Atmospheric Science and Technology Directorate, Environment Canada, Toronto, ON, M3H 5T4, Canada. jeff.brook@ec.gc.ca.
Renaud VincentInhalation Toxicology Laboratory, Hazard Identification Division, Environmental Health Science and Research Bureau, Health Canada, 0802B Tunney's Pasture, Ottawa, ON, K1A 0K9, Canada. renaud.vincent@hc-sc.gc.ca.
Health Canada · CAAir Canada · CAEnvironment and Climate Change Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExposure to coarse, fine, and ultrafine particles is associated with adverse population health impacts. We investigated whether size-fractionated particles collected repeatedly in the vicinity of industrial (steel mills and associated coking operations, wastewater treatment), high traffic, and residential areas display systematic differences in biological potency.

methodsParticulate matter (PM<0.1, PM0.1-0.5, PM0.5-2.5, PM2.5-10, PM>10) samples collected at sites within Windsor, Ontario, were screened for biological potency in human A549 lung epithelial and murine J774A.1 macrophage-like cells using cytotoxicity bioassays (cellular ATP, resazurin reduction, lactate dehydrogenase (LDH) release), cytokine production, and transcript profiles. Potency was determined from the slope of each dose-effect relationship.

resultsCytotoxic potency varied across size fractions and within a fraction across sites and sampling periods, suggesting that particle composition, in addition to size and mass, affected particle toxicity. While ATP and LDH profiles showed some similarity, resazurin reduction (a measure of metabolic activity) exhibited a unique pattern of response, indicating that the cytotoxicity assays were sensitive to distinct particle characteristics. Chemical speciation varied in relation to prevailing winds, consistent with enrichment of source emissions (e.g. higher metal and polycyclic aromatic hydrocarbon content downwind of the industrial site). Notwithstanding this variability, site-dependent differences in particle toxicity were evident, including greater potency of coarse fractions at the industrial site and of ultrafine particles at the traffic site (Site × Size interactions, p < 0.05). Regression of potency against particle constituents revealed correlations between resazurin reduction, induction of metal-responsive genes, and metal content, which were particularly strong for the coarse fraction, and between cytokine release and endotoxin, suggesting that these factors were important drivers of biological effects that explain, at least in part, the contrasting potencies of particles compared on an equivalent mass basis.

conclusionsThe data show that 1) particle potency and composition can exhibit significant temporal variation in relation to source contributions; 2) sources may differentially impact the potency of specific size fractions; and 3) particle constituents, notably metals and endotoxin, may elicit distinct biological responses. Together, the data are consistent with the notion that sources and composition, in addition to size and mass concentration, are relevant to particle toxicity.

Indexed as

Urban HealthAdenosine TriphosphateAnimalsCell Line, TumorCytokinesDose-Response Relationship, DrugEnvironmental MonitoringEpithelial CellsGene Expression ProfilingHumansIndustrial WasteInflammation MediatorsInhalation ExposureL-Lactate DehydrogenaseLungMacrophagesAdenosine TriphosphateCytokinesIndustrial WasteInflammation MediatorsL-Lactate DehydrogenaseParticulate MatterVehicle Emissions

Identifiers

PMID26178321
PMCPMC4502610
OpenAlexW1830298985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.